Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Roche said the company sees a path forward for combining giredestrant with another drug. - Sedat Suna/Getty Images Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its primary objective. The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to generate annual peak sales above 3 billion Swiss francs ($3.87 billion). The drugmaker, though, said there was still a path forward for the medicine. Most Read from The Wall Street Journal The Long-Feared Persian Gulf Oil Squeeze Is Upon Us A New Generation of Mall Rats Has Arrived AI Needs Management Consultants After All America's Natural-Gas Bounty Is Cushioning U.S. Markets From Global Shocks Activist Starboard Takes Big Stake in French-Fry Maker Lamb Weston Shares in Roche fell as much as 8% in early morning trade Monday, amid broad-based losses across European stocks due
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics [Yahoo! Finance]Yahoo! Finance
- Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology [Yahoo! Finance]Yahoo! Finance
- FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Roche Falters In A Key Breast Cancer Readout [Seeking Alpha]Seeking Alpha
- Roche's Breast Cancer Drug Falls Short In Phase 3 Study [Yahoo! Finance]Yahoo! Finance